Establishment and primary application of a mouse model with hepatitis B virus replication
- PMID: 17879401
- PMCID: PMC4171321
- DOI: 10.3748/wjg.v13.i40.5324
Establishment and primary application of a mouse model with hepatitis B virus replication
Abstract
Aim: To establish a rapid and convenient animal model with hepatitis B virus (HBV) replication.
Methods: A naked DNA solution of HBV-replication-competent plasmid was transferred to BALB/C mice via the tail vein, using a hydrodynamic in vivo transfection procedure. After injection, these mice were sacrificed on d 1, 3, 4, 5, 7 and 10. HBV DNA replication intermediates in the liver were analyzed by Southern blot hybridization. The expression of hepatitis B core antigen (HBcAg) and hepatitis B surface antigen (HBsAg) in the liver was checked by immunohistochemistry. Serum HBsAg and hepatitis B e antigen (HBeAg) was detected by enzyme-linked immunosorbent assay (ELISA). Inhibition of HBV replication was compared in HBV replication model mice treated intraperitoneally with polyinosinic-polytidylin acid (polyIC) or phosphate-buffered saline (PBS).
Results: After hydrodynamic in vivo transfection, HBV DNA replication intermediates in the mouse liver were detectable on d 1 and abundant on d 3 and 4, the levels were slightly decreased and remained relatively stable between d 5 and 7, and were almost undetectable on d 10. The expression patterns of HBcAg and HBsAg were similar to that of HBV replication intermediate DNA, except that they reached a peak on d 1 after injection. No obvious differences in HBV DNA replication intermediates were observed in the left, right and middle lobes of the liver. After treatment with polyIC, the level of HBV intermediate DNA in the liver was lower than that in the control mice injected with PBS.
Conclusion: A rapid and convenient mouse model with a high level of HBV replication was developed and used to investigate the inhibitory effect of polyIC on HBV replication, which provides a useful tool for future functional studies of the HBV genome.
Figures







Similar articles
-
[Effects of amantadine and biphenyl dimethyl dicarboxylate on hepatitis B virus in hepatitis B virus replication mice].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2014 Apr;31(2):400-4. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2014. PMID: 25039150 Chinese.
-
High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.World J Gastroenterol. 2015 Mar 28;21(12):3527-36. doi: 10.3748/wjg.v21.i12.3527. World J Gastroenterol. 2015. PMID: 25834317 Free PMC article.
-
Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.World J Gastroenterol. 2006 Jul 28;12(28):4492-7. doi: 10.3748/wjg.v12.i28.4492. World J Gastroenterol. 2006. PMID: 16874860 Free PMC article.
-
Natural history of chronic hepatitis B virus infection: an immunopathological study.J Gastroenterol Hepatol. 1997 Oct;12(9-10):S218-22. doi: 10.1111/j.1440-1746.1997.tb00503.x. J Gastroenterol Hepatol. 1997. PMID: 9407340 Review.
-
In Vivo Mouse Models for Hepatitis B Virus Infection and Their Application.Front Immunol. 2021 Oct 29;12:766534. doi: 10.3389/fimmu.2021.766534. eCollection 2021. Front Immunol. 2021. PMID: 34777385 Free PMC article. Review.
Cited by
-
Role and functional domain of hepatitis B virus X protein in regulating HBV transcription and replication in vitro and in vivo.Viruses. 2013 May 22;5(5):1261-71. doi: 10.3390/v5051261. Viruses. 2013. PMID: 23698398 Free PMC article.
-
Interferon-alpha responsible EPN3 regulates hepatitis B virus replication.Front Med (Lausanne). 2022 Jul 22;9:944489. doi: 10.3389/fmed.2022.944489. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35935763 Free PMC article.
-
The Prevalence and Replication Capacity of a Tibetan Dominant HBV Strain, C/D Recombinant.Biomed Res Int. 2017;2017:8415907. doi: 10.1155/2017/8415907. Epub 2017 Jun 21. Biomed Res Int. 2017. PMID: 28713830 Free PMC article.
-
The efficacy of zinc finger antiviral protein against hepatitis B virus transcription and replication in tansgenic mouse model.Virol J. 2015 Feb 13;12:25. doi: 10.1186/s12985-015-0245-0. Virol J. 2015. PMID: 25889209 Free PMC article.
-
RPB5-Mediating Protein Suppresses Hepatitis B Virus (HBV) Transcription and Replication by Counteracting the Transcriptional Activation of Hepatitis B virus X Protein in HBV Replication Mouse Model.Jundishapur J Microbiol. 2015 Sep 22;8(9):e21936. doi: 10.5812/jjm.21936. eCollection 2015 Sep. Jundishapur J Microbiol. 2015. PMID: 26495109 Free PMC article.
References
-
- Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981;2:1129–1133. - PubMed
-
- Liu FJ, Liu C, Deng LY, Zhou TY, Liu L, Tang H. Hydrodynamics-based in vivo transfection results in high level expression of HBsAg in mouse liver. Huaxi Yixue. 2005;20:697–699.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical